Novel functionalization strategies of polymeric nanoparticles as carriers for brain medications.

about

Nanomedicine formulations for the delivery of antiviral drugs: a promising solution for the treatment of viral infections.Peptide Mediated Brain Delivery of Nano- and Submicroparticles: a Synergistic Approach.

P2860

Q40105941-06B3FBA6-A38C-41C3-9501-538B2AD91119 Q47933170-D7299080-919F-47EB-8ACE-5B3373A69253

P2860

Novel functionalization strategies of polymeric nanoparticles as carriers for brain medications.

Item

http://www.wikidata.org/entity/Q39154878

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Novel functionalization strate ...... arriers for brain medications.

@en

Novel functionalization strate ...... arriers for brain medications.

@nl

type

Item

label

Novel functionalization strate ...... arriers for brain medications.

@en

Novel functionalization strate ...... arriers for brain medications.

@nl

prefLabel

Novel functionalization strate ...... arriers for brain medications.

@en

Novel functionalization strate ...... arriers for brain medications.

@nl

P1476

Novel functionalization strate ...... arriers for brain medications.

@en

P2093

Alessandro Romeo

http://www.w3.org/2001/XMLSchema#string

Corinne Portioli

http://www.w3.org/2001/XMLSchema#string

Donatella Benati

http://www.w3.org/2001/XMLSchema#string

Michele Bovi

http://www.w3.org/2001/XMLSchema#string

Stefano Dusi

http://www.w3.org/2001/XMLSchema#string

P2860

Tools for integrated sequence-structure analysis with UCSF Chimera.

Nanoparticles for brain drug delivery

The blood-brain barrier: bottleneck in brain drug development

CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice

Nanoparticle-mediated brain drug delivery: Overcoming blood-brain barrier to treat neurodegenerative diseases

Apolipoprotein E and apolipoprotein E receptors: normal biology and roles in Alzheimer disease

A carrier for non-covalent delivery of functional beta-galactosidase and antibodies against amyloid plaques and IgM to the brain

Astrocytes: biology and pathology

High-resolution structures of mutants of residues that affect access to the ligand-binding cavity of human lipocalin-type prostaglandin D synthase

UCSF Chimera--a visualization system for exploratory research and analysis

P304

847-858

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/JBM.A.35961

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

105

http://www.w3.org/2001/XMLSchema#string

P50

P577

2016-11-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27885823

http://www.w3.org/2001/XMLSchema#string

Novel functionalization strategies of polymeric nanoparticles as carriers for brain medications.

about

P2860

P2860

Novel functionalization strategies of polymeric nanoparticles as carriers for brain medications.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698